mdwho&how
페이지 정보
본문
An MRD discussion: when, who and how
Maria-Victoria Mateos, MD, PhD from University Hospital of Salamanca, Salamanca, Spain, Nikhil Munshi, MD, from Dana-Farber Cancer Institute, Boston, MA and Faith Davies, MBBCh, MRCP, MD, FRCPath, from NYU Langone Medical Center, New York, NY, discuss their views on which patients should undergo measurable residual disease (MRD) testing, at what time points testing should be carried out and how MRD should be tested. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
The Why, Who and How of Treatment Free Remission
This video is part of a larger CE/CME Certified program entitled: Recent Advances in TKI Therapy in CML. You can receive free CME credit, view this video, and download slides from the presentation at MedEdOnTheGo.com
Optimizing Insulin Therapy in Children with Diabetes Prof. Shereen Abdelghaffar
Optimizing Insulin Therapy in Children with Diabetes Prof. Shereen Abdelghaffar
Maria-Victoria Mateos, MD, PhD from University Hospital of Salamanca, Salamanca, Spain, Nikhil Munshi, MD, from Dana-Farber Cancer Institute, Boston, MA and Faith Davies, MBBCh, MRCP, MD, FRCPath, from NYU Langone Medical Center, New York, NY, discuss their views on which patients should undergo measurable residual disease (MRD) testing, at what time points testing should be carried out and how MRD should be tested. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
The Why, Who and How of Treatment Free Remission
This video is part of a larger CE/CME Certified program entitled: Recent Advances in TKI Therapy in CML. You can receive free CME credit, view this video, and download slides from the presentation at MedEdOnTheGo.com
Optimizing Insulin Therapy in Children with Diabetes Prof. Shereen Abdelghaffar
Optimizing Insulin Therapy in Children with Diabetes Prof. Shereen Abdelghaffar
... 
댓글목록
등록된 댓글이 없습니다.